Baskett R J, MacDougall C E, Ross D B
Department of Cardiovascular Surgery, Dalhousie University and The Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada.
Ann Thorac Surg. 1999 Feb;67(2):462-5. doi: 10.1016/s0003-4975(98)01195-3.
The incidence of mediastinitis after cardiac surgical intervention is reported to be between 0.15% and 5% and is a major cause of postoperative morbidity. A number of risk factors have been identified, most of which are not modifiable. It is our contention that this complication can be reduced to a minimum by the consistent application of good operative technique and postoperative management.
We reviewed the records of all 9,771 patients who underwent cardiac surgical procedures between 1987 and 1997. All operations were performed using a common skin preparation, draping, and antibiotic prophylaxis. Cases of mediastinitis were defined according to Centers for Disease Control and Prevention criteria and were identified from three sources: medical records database, hospital infection control, and the Society of Thoracic Surgeons database. Risk factors were assessed using chi2 and Fisher's exact tests.
Of 24 patients identified as having deep sternal wound infection (incidence, 0.25%), 2 died (mortality rate, 8.3%), 18 required reoperation (75%), and only 4 needed pectoral muscle flaps. Statistical analysis revealed only the presence of chronic obstructive pulmonary disease as a significant risk factor (p < 0.01). Other factors, including diabetes, renal failure, smoking, sex, age, reoperation, morbid obesity, and steroid use, were not significant. The use of internal mammary arteries (single or bilateral) was not associated with mediastinitis. Postoperative complications, including prolonged ventilation, inotropic support, and the need for blood products, were not significant risk factors. The patients who developed mediastinitis were more likely to be readmitted to the hospital (p < 0.005) and more likely to require reoperation (p < 0.005).
In a large patient series we found a low incidence of mediastinitis (0.25%) and an even lower incidence of required reoperation (0.19%). Except for the use of bone wax and the use of bilateral mammary arteries in diabetic patients, none of the previously identified risk factors are modifiable. We believe that with strict adherence to perioperative aseptic technique, attention to hemostasis, and precise sternal closure, a very low incidence of mediastinitis can be achieved.
据报道,心脏外科手术后纵隔炎的发生率在0.15%至5%之间,是术后发病的主要原因。已确定了许多风险因素,其中大多数是不可改变的。我们认为,通过持续应用良好的手术技术和术后管理,这种并发症可以降至最低。
我们回顾了1987年至1997年间接受心脏外科手术的所有9771例患者的记录。所有手术均采用相同的皮肤准备、铺巾和抗生素预防措施。纵隔炎病例根据疾病控制和预防中心的标准定义,并从三个来源确定:病历数据库、医院感染控制部门和胸外科医师协会数据库。使用卡方检验和费舍尔精确检验评估风险因素。
在24例被确定为患有深部胸骨伤口感染的患者中(发生率为0.25%),2例死亡(死亡率为8.3%),18例需要再次手术(75%),只有4例需要胸肌瓣。统计分析显示,只有慢性阻塞性肺疾病是一个显著的风险因素(p<0.01)。其他因素,包括糖尿病、肾衰竭、吸烟、性别、年龄、再次手术、病态肥胖和使用类固醇,均不显著。使用胸廓内动脉(单侧或双侧)与纵隔炎无关。术后并发症,包括通气时间延长、使用血管活性药物支持和需要输血制品,均不是显著的风险因素。发生纵隔炎的患者更有可能再次入院(p<0.005),也更有可能需要再次手术(p<0.005)。
在一个大型患者系列中,我们发现纵隔炎的发生率较低(0.25%),需要再次手术的发生率甚至更低(0.19%)。除了在糖尿病患者中使用骨蜡和双侧胸廓内动脉外,以前确定的风险因素均不可改变。我们认为,通过严格遵守围手术期无菌技术、注意止血和精确的胸骨闭合,可以实现非常低的纵隔炎发生率。